The TLR4/NF-κB signaling pathway plays a central role in driving inflammation via the differentiation and amplification of T helper17 together with over-expression of inflammatory mediators [33,34], thus promoting susceptibility to SS. This evidence concerns the gene TLR4 and synovial sarcoma.